Who is sponsoring RSV SB?

RSV SB is sponsored by Emory University.

What condition does RSV SB study?

RSV SB studies Respiratory Syncytial Virus (RSV).

What drugs are being tested in RSV SB?

Interventions: Moderna RSV vaccine.

What is the status of RSV SB?

RSV SB is currently ACTIVE_NOT_RECRUITING.

Last reviewed 2026-01-20 · How we verify

Systems Biological Analysis of Immune Responses to RSV Vaccine (RSV SB)

NCT07185399 Phase 4 ACTIVE_NOT_RECRUITING

The purpose of this study is to characterize the immune response to the FDA-approved mRNA-based RSV vaccine in adults ≥60 years of age, using a systems biology approach. The study aims to generate high-resolution immunologic and systems biology data following vaccination to identify early biomarkers of response and gain mechanistic insight into host immunity.

Details

Lead sponsor	Emory University
Phase	Phase 4
Status	ACTIVE_NOT_RECRUITING
Enrolment	14
Start date	2025-10-13
Completion	2026-07

Conditions

Respiratory Syncytial Virus (RSV)

Interventions

Moderna RSV vaccine

Primary outcomes

Antibody Titers — Days 28 and 180 post-vaccination
The magnitude of RSV-specific antibody responses following vaccination with an mRNA RSV vaccine (MRESVIA) is assessed as antibody titers at Days 28 and 180 post-vaccination.

Countries

United States